Welcome to the eCancerTrials.com National Cancer Clinical Trials Database. When you or a loved one are diagnosed with cancer, knowing every treatment option available is your first step in receiving the most complete care. Your treatment plan may include choosing to participate in a cancer clinical trial. Clinical trials in cancer are research studies designed to evaluate new cancer treatment, management, and prevention options. Clinical trials conducted with cancer patients evaluate the safety and effectiveness of new or modified cancer treatment strategies. New anticancer drugs, unique approaches to surgery and radiation therapy are used as well as various combinations of cancer treatments.

Many medical professionals encourage those diagnosed with cancer to at least consider participating in a clinical trial in addition to other treatment options. Furthermore, many treatment options for cancer patients are only available through clinical trials, making participation in a trial the only way to access certain therapies. So if you are not evaluating potential cancer treatments accessible through the clinical trials process alongside current standard therapies, you're not weighing all of your available options.

Although there is currently no single, comprehensive source of available clinical trials, eCancerTrials.com’s provides information on more than 2,000 clinical trials being conducted by leading cancer researchers from all 50 states. These clinical trials evaluate novel treatment approaches and new cancer drugs in all major cancer types, including breast cancer, colon cancer, prostate cancer, lung cancer, lymphoma, leukemia, and many others.

eCancerTrials.com is a free and confidential cancer clinical trials matching and referral service. This resource is provided to cancer patients and their caregivers by leading cancer information specialists at CancerConsultants.com. Interested patients and their advocates may use this resource to:

• Search—free of charge—for clinical trials applicable to your situation.
• Search without sharing personal information until you find a trial that is appropriate. At this point you can directly call or e-mail the cancer clinic or center conducting the trial. In this manner your privacy is respected and ensured.
• eCancerTrials.com provides interested patients and their family members with additional services to help locate appropriate clinical trials.

Use the search engine below to look for clinical trials, or learn more about clinical trials.

Search by cancer type:

Select a cancer type --------------------------------- Acute Lymphoid Leukemia Acute Myeloid Leukemia Anal Cancer Any Cancer Any Cancer Type Bladder Cancer Blood Disorders Bone Metastasis Brain/Central Nervous System Cancer Breast Cancer Cervical Cancer Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Colorectal Cancer Esophageal Cancer Gastric Cancer Germ Cell Cancer Head & Neck Cancers High Risk Prostate Cancer Hodgkin's Lymphoma Liver Cancer Lymphoma Malignant Melanoma Malignant Mesothelioma Merkel Cell Cancer Multiple Myeloma Myelodysplastic Syndromes Neuroblastoma Non Small Cell Lung Cancer Non-Hodgkin's Lymphoma - High Grade Non-Hodgkin's Lymphoma - Intermediate Grade Non-Hodgkin's Lymphoma - Low Grade Non-Hodgkin's Lymphoma - Mantle Cell Osteosarcoma Other Ovarian Cancer Pancreatic Cancer Prostate Cancer Renal Cell (Kidney) Cancer Retinoblastoma Rhabdomyosarcoma Sarcoma Skin Cancer Small Cell Lung Cancer Soft Tissue Sarcoma Solid Tumors Supportive Care (Side Effects) Testicular Cancer-Non-Seminoma Testicular Cancer-Seminoma Thymic Thyroid Cancer Unknown Primary Uterine (Endometrial) Cancer Vaginal Cancer Wilm's Tumor  

Filter by:

All cancer stages --------------------------------- Stage 1-3 Stage 4 Recurrent/Refractory All States ------------------------------- Northeast Region Southeast Region Midwest Region Northwest Region Southwest Region ------------------------------- Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucy Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

Displaying clinical trials in "Pancreatic Cancer" in "All cancer stages" in "All States":

Protocol No.	Title
REFMAL28-P	A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-P
INST0603C	Chart Review on Patients with Unresectable/Metastatic Pancreatic Cancer Treated in the UNM Cancer Center
REFMAL30-P	A PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-P
80603	A Phase II study of Sunitinib Malate (SU11248) in Patients with Previously Treated Pancreatic Adenocarcinoma with Measurable Metastatic Disease following progression on front-line Gemcitabine-based Therapy.
REFMAL39	A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
PAN003	A Phase III Randomized, Controlled Study to Evaluate the Safety and Efficacy of an Investigational Vaccine in Combination with GM-CSF Versus Best Supportive Care or Palliative Chemotherapy in Patients with Metastatic (Stage IV) Adenocarcinoma of the Pancreas Who Have Failed a Gemcitabine-Containing Chemotherapy Regimen
SGI-RUB-048	A Double-Blind, Randomized, Multi-center, Study of Orathecin Capsules Plus Gemcitabine Versus Placebo Capsules Plus Gemcitabine (With an Open-Label Single Arm Pre-Randomization Phase) in Chemonaive Patients With Non-Resectable Pancreatic Cancer
DA-1-09-CA046	Randomized, Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas.
AbraxisCA046	A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
INST0802	Phase II Trial of Combination Irinotecan, Oxaliplatin and Cetuximab for Patients with Locally Advanced or Metastatic Pancreatic Cancer
REFMAL31	A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
REFMAL32	AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
REFMAL33	A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS
REFMAL34	A PHASE I STUDY OF TOPOTECAN IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS
A4061028	A randomized, double-blind phase 3 study of gemcitabine plus AG-013736 versus gemcitabine plus placebo for the first-line treatment of patients with locally advanced, unresectable or metastatic pancreatic cancer.
S0727	A Phase I and Randomized Phase II Trial of Gemcitabine + Erlotinib + IMC-A12 vs Gemzar + Erlotinib as First-Line Treatment in Patients with Metastatic Pancreatic Cancer
INST0613C	Retrospective analysis of responses and survival in patients with locally advanced or metastatic pancreatic cancer treated in the CRTC from 10/1/2001 to 6/30/2006: to describe and compare the clinical outcomes in patients with pancreatic cancer treated with either combination of irinotecan, oxaliplatin and cetuximab or other Gemcitabine-based regimen.